A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule

Isabel L. Jackson, Puting Xu, Caroline Hadley, Barry Katz, Ross McGurk, Julian D. Down, Zeljko Vujaskovic

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The purpose of preclinical murine model development is to establish that the pathophysiological outcome of the rodent model of radiation-induced lung injury is sufficiently representative of the anticipated pulmonary response in the human population. This objective is based on concerns that the C57BL/6J strain may not be the most appropriate preclinical model of lethal radiation lung injury in humans. In this study, the authors assessed this issue by evaluating the relationship between morbidity (pulmonary function, histopathologic damage) and mortality among three strains of mice: C57BL/6J, CBA/J, and C57L/J. These different strains display variations in latency and phenotypic expression of radiation-induced lung damage. By comparing the response of each strain to the human pulmonary response, an appropriate animal model(s) of human radiation-induced pulmonary injury was established. Observations in the C57L/J and CBA/J murine models can be extrapolated to the human lung for evaluation of the mechanisms of action of radiation as well as future efficacy testing and approving agents that fall under the "Animal Rule" of the U.S. Food and Drug Administration (FDA) (21 CFR Parts 314 and 601).

Original languageEnglish
Pages (from-to)463-473
Number of pages11
JournalHealth Physics
Volume103
Issue number4
DOIs
StatePublished - Oct 2012

Fingerprint

Lung Injury
United States Food and Drug Administration
Rodentia
Radiation
Lung
Radiation Injuries
Inbred C57BL Mouse
Animal Models
Morbidity
Mortality
Population

Keywords

  • lungs rodent
  • modeling dose assessment
  • radiation damage
  • radiation medical

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Health, Toxicology and Mutagenesis
  • Epidemiology

Cite this

A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule. / Jackson, Isabel L.; Xu, Puting; Hadley, Caroline; Katz, Barry; McGurk, Ross; Down, Julian D.; Vujaskovic, Zeljko.

In: Health Physics, Vol. 103, No. 4, 10.2012, p. 463-473.

Research output: Contribution to journalArticle

Jackson, Isabel L. ; Xu, Puting ; Hadley, Caroline ; Katz, Barry ; McGurk, Ross ; Down, Julian D. ; Vujaskovic, Zeljko. / A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule. In: Health Physics. 2012 ; Vol. 103, No. 4. pp. 463-473.
@article{08a1ecd03cc04367a043272a786108e1,
title = "A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule",
abstract = "The purpose of preclinical murine model development is to establish that the pathophysiological outcome of the rodent model of radiation-induced lung injury is sufficiently representative of the anticipated pulmonary response in the human population. This objective is based on concerns that the C57BL/6J strain may not be the most appropriate preclinical model of lethal radiation lung injury in humans. In this study, the authors assessed this issue by evaluating the relationship between morbidity (pulmonary function, histopathologic damage) and mortality among three strains of mice: C57BL/6J, CBA/J, and C57L/J. These different strains display variations in latency and phenotypic expression of radiation-induced lung damage. By comparing the response of each strain to the human pulmonary response, an appropriate animal model(s) of human radiation-induced pulmonary injury was established. Observations in the C57L/J and CBA/J murine models can be extrapolated to the human lung for evaluation of the mechanisms of action of radiation as well as future efficacy testing and approving agents that fall under the {"}Animal Rule{"} of the U.S. Food and Drug Administration (FDA) (21 CFR Parts 314 and 601).",
keywords = "lungs rodent, modeling dose assessment, radiation damage, radiation medical",
author = "Jackson, {Isabel L.} and Puting Xu and Caroline Hadley and Barry Katz and Ross McGurk and Down, {Julian D.} and Zeljko Vujaskovic",
year = "2012",
month = "10",
doi = "10.1097/HP.0b013e31826386ef",
language = "English",
volume = "103",
pages = "463--473",
journal = "Health Physics",
issn = "0017-9078",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule

AU - Jackson, Isabel L.

AU - Xu, Puting

AU - Hadley, Caroline

AU - Katz, Barry

AU - McGurk, Ross

AU - Down, Julian D.

AU - Vujaskovic, Zeljko

PY - 2012/10

Y1 - 2012/10

N2 - The purpose of preclinical murine model development is to establish that the pathophysiological outcome of the rodent model of radiation-induced lung injury is sufficiently representative of the anticipated pulmonary response in the human population. This objective is based on concerns that the C57BL/6J strain may not be the most appropriate preclinical model of lethal radiation lung injury in humans. In this study, the authors assessed this issue by evaluating the relationship between morbidity (pulmonary function, histopathologic damage) and mortality among three strains of mice: C57BL/6J, CBA/J, and C57L/J. These different strains display variations in latency and phenotypic expression of radiation-induced lung damage. By comparing the response of each strain to the human pulmonary response, an appropriate animal model(s) of human radiation-induced pulmonary injury was established. Observations in the C57L/J and CBA/J murine models can be extrapolated to the human lung for evaluation of the mechanisms of action of radiation as well as future efficacy testing and approving agents that fall under the "Animal Rule" of the U.S. Food and Drug Administration (FDA) (21 CFR Parts 314 and 601).

AB - The purpose of preclinical murine model development is to establish that the pathophysiological outcome of the rodent model of radiation-induced lung injury is sufficiently representative of the anticipated pulmonary response in the human population. This objective is based on concerns that the C57BL/6J strain may not be the most appropriate preclinical model of lethal radiation lung injury in humans. In this study, the authors assessed this issue by evaluating the relationship between morbidity (pulmonary function, histopathologic damage) and mortality among three strains of mice: C57BL/6J, CBA/J, and C57L/J. These different strains display variations in latency and phenotypic expression of radiation-induced lung damage. By comparing the response of each strain to the human pulmonary response, an appropriate animal model(s) of human radiation-induced pulmonary injury was established. Observations in the C57L/J and CBA/J murine models can be extrapolated to the human lung for evaluation of the mechanisms of action of radiation as well as future efficacy testing and approving agents that fall under the "Animal Rule" of the U.S. Food and Drug Administration (FDA) (21 CFR Parts 314 and 601).

KW - lungs rodent

KW - modeling dose assessment

KW - radiation damage

KW - radiation medical

UR - http://www.scopus.com/inward/record.url?scp=84866047146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866047146&partnerID=8YFLogxK

U2 - 10.1097/HP.0b013e31826386ef

DO - 10.1097/HP.0b013e31826386ef

M3 - Article

C2 - 22929472

AN - SCOPUS:84866047146

VL - 103

SP - 463

EP - 473

JO - Health Physics

JF - Health Physics

SN - 0017-9078

IS - 4

ER -